—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Fagron NV (FAGR.BR) — the peer cohort

As of 2026-10-06 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Fagron NV ranks 7 of 12 in its cohort on the Closelooknet composite (53/100) — the cohort is led by BB Biotech AG at 73/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
FAGR.BR Fagron NV 53 47 57 60 info 8.9%
ROVI.MC Laboratorios Farmaceuticos ROVI 61 25 78 52 warn 31.8%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 55 91 58 42 ok 4.2%
ALM.MC Almirall S.A. 53 18 46 68 warn 26.2%
APTX.TO Apotex Health Corp 46 34 59 50 — —
RDY Dr. Reddy’s Laboratories Ltd ADR 46 29 44 63 info 19.5%
SFZN.SW Siegfried Holding Ltd 42 28 45 55 info 30.4%
TUB.BR Tubize-Fin 25 11 20 27 warn 32%
BION.SW BB Biotech AG 73 59 96 81 info 12.9%
DXCM DexCom Inc 65 78 81 37 bull 6.1%
ANN.AU Ansell Ltd 64 93 49 53 ok 0.9%
ONC BeiGene, Ltd. 64 78 66 32 ok 5.8%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-06

Quick answers

Who are Fagron NV's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Almirall S.A. (ALM.MC), Apotex Health Corp (APTX.TO), Dr. Reddy’s Laboratories Ltd ADR (RDY), Siegfried Holding Ltd (SFZN.SW), Tubize-Fin (TUB.BR), BB Biotech AG (BION.SW) and others.

How does FAGR.BR score against its peers?

Fagron NV's composite reads 53/100, ranking 7 of 12 in its cohort as of 2026-10-06; the cohort's highest composite is BB Biotech AG at 73/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.